Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|October 2, 2014
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemiaAshish Banerjee, Nicole A Mifsud, Robert Bird, et al.
Waste Management (New York, N.Y.)|March 16, 2025
Upcycling textile derived microplastics waste collected from washer and dryers to carbonaceous products using hydrothermal carbonizationSilvia Parrilla-Lahoz, Elena Jiménez-Páez, Mateus G Masteghin, et al.
Blood|February 17, 2018
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCLFrank Vari, David Arpon, Colm Keane, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 14, 2003
Recombinant activated factor VII for the treatment of life-threatening haemorrhageJohn W Eikelboom, Robert Bird, David Blythe, et al.
Research and Practice in Thrombosis and Haemostasis|October 3, 2022
Treatment of immune thrombocytopenia in Australian adults: A multicenter retrospective observational studyAdam Rosenberg, Catelyn Cashion, Fariya Ali, et al.
American Journal of Lifestyle Medicine|April 20, 2026
Effects of Traditional Mediterranean Physical Activity on Physical and Mental Health: A Systematic ReviewAmalia Sidossis, Konstantinos D Tambalis, Catherine Itsiopoulos, et al.
Research and Practice in Thrombosis and Haemostasis|December 19, 2022
Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patientsPhilip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, et al.
The Journal of Sports Medicine and Physical Fitness|November 24, 2025
Traditional Mediterranean physical activity: integration of active lifestyle behaviors and exercise with social interactions as part of daily lifeMehdi Kushkestani, Leonidas G Karagounis, Rob Lawson, et al.
Blood Advances|February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopeniaDavid J Kuter, Jiri Mayer, Merlin Efraim, et al.
American Journal of Hematology|January 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B StudyNichola Cooper, A J Gerard Jansen, Robert Bird, et al.
Pageof 5